SureTrader Advertisement
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, baryoboy, skorz
Search This Board:
Last Post: 7/23/2016 7:26:00 AM - Followers: 465 - Board type: Free - Posts Today: 1
 

                         


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=141220
 

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=125904



Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=127990
 


Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=136848

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=133983

EPGL and AT&T Sign Development Agreement
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=132040



About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
LINKS TO SHARE RETIREMENT
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**




Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twitter @epglMED  https://twitter.com/EPGLMed
Follow EPGL on the WEB at http://www.epglmed.com





 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#102976  Sticky Note Link to EP Global Communications 4/28/16 Conference call; flaflyersfan 04/29/16 10:15:58 AM
#97811  Sticky Note EP Global Communications, Inc. Reaches Settlement Agreement with vikingzskillz 02/09/16 02:25:24 PM
#95482  Sticky Note Press releases or other company communication should not Brian !!Retired!! 01/12/16 12:14:18 PM
#107061   Show me proof that J&J has agreements with jhnvtjll 07/22/16 11:33:49 PM
#107060   That's not true. I've personally sold 900,000 jhnvtjll 07/22/16 11:23:32 PM
#107059   That's because registration is done thru the smartvision2016.com jhnvtjll 07/22/16 11:18:39 PM
#107058   Proof? Because you said that 4 Valiant 07/22/16 09:52:52 PM
#107057   Door opens with patent approval. Epgl needs to kura 07/22/16 09:51:59 PM
#107056   Valiant, AJW will liquidate their EPGL position before flaflyersfan 07/22/16 07:27:42 PM
#107055   Licensing deals and buyout potential are what those vikingzskillz 07/22/16 07:10:11 PM
#107054   Some will get USPTO blessings others will not. vikingzskillz 07/22/16 07:09:06 PM
#107053   Many EPGL patent applications in public domain searches, vikingzskillz 07/22/16 07:08:13 PM
#107052   Doubt it, personally look forward to it. $$$ vikingzskillz 07/22/16 07:07:05 PM
#107051   "See the tweets below..." Donguri 07/22/16 06:12:50 PM
#107049   Vegas will be fun! Koog 07/22/16 05:41:30 PM
#107048   Buyout ?? licensing deals ?? franck92 07/22/16 05:39:59 PM
#107047   Very much so gr8f1. EPGL's technology will H8ster 07/22/16 05:16:43 PM
#107046   Yep very well said. Vegas will be fun! Valiant 07/22/16 04:55:51 PM
#107045   But if you want that nobody can see Bibioo 07/22/16 04:54:57 PM
#107044   I didn't see today's tweet earlier. Looks like kura 07/22/16 04:16:50 PM
#107043   True... I should have said "which it would gr8f1 07/22/16 03:39:54 PM
#107042   "if the technology is historically groundbreaking... which it is." Stock Barber 07/22/16 03:34:36 PM
#107041   IMO that is a poor analogy. A buyout gr8f1 07/22/16 03:20:58 PM
#107040   Nice post Franck92! Well thought out. H8ster 07/22/16 03:19:08 PM
#107039   "Approved patents lead to the buyout." Stock Barber 07/22/16 03:09:00 PM
#107038   Thats basic risk assessment. Long term shareholders H8ster 07/22/16 02:55:18 PM
#107037   http://lowres.cartoonstock.com/retail-gift_shop-gifts-smoke_and_mirrors-eas MarkHart66 07/22/16 02:49:16 PM
#107036   Patents alone will bring a small bump in Valiant 07/22/16 02:34:53 PM
#107035   EPGL is at the point it will either Valiant 07/22/16 02:33:26 PM
#107034   I don't think it takes that long at kura 07/22/16 02:32:38 PM
#107033   Put them up for sale. Guaranteed someone Valiant 07/22/16 02:25:29 PM
#107032   Yeah Valiant, it'll be a while longer until H8ster 07/22/16 02:25:08 PM
#107031   In the last 3 years they are still Valiant 07/22/16 02:25:03 PM
#107030   In 4 years, little pissant $EPGL will have Atlanta1 07/22/16 02:15:12 PM
#107029   Ya it will happen just not for a Valiant 07/22/16 02:08:38 PM
#107027   I would like to sell my shares but baryoboy 07/22/16 01:36:37 PM
#107026   It makes no sense. The only opinions that Atlanta1 07/22/16 01:26:23 PM
#107025   Like I said previously VR will be marketing dragonsfire 07/22/16 01:23:19 PM
#107024   Many reasons. They are working so hard Valiant 07/22/16 01:19:46 PM
#107023   If that is the case, why should it Atlanta1 07/22/16 01:08:29 PM
#107022   I am not moving anything. I have claimed Valiant 07/22/16 12:52:14 PM
#107020   They didn't guarantee that. They said it could Valiant 07/22/16 12:51:02 PM
#107019   but they said big $ in 2015 w/o nowy257 07/22/16 12:43:30 PM
#107018   Not me. The tech won't even be ready Valiant 07/22/16 12:42:19 PM
#107017   mgm said so nowy257 07/22/16 12:39:08 PM
#107016   I have never claimed anything in 2015 or Valiant 07/22/16 12:37:00 PM
#107014   it is only your opinion. We want and franck92 07/22/16 11:54:02 AM
#107013   I wouldn't want to say that but I franck92 07/22/16 11:51:17 AM
#107012   Hayes and his IP "team": Atlanta1 07/22/16 11:50:30 AM
#107011   $$$ EPGL $$$ vikingzskillz 07/22/16 11:44:40 AM
#107010   Epgl technology seems great, that is why Coopervision franck92 07/22/16 11:40:49 AM
#107009   $EPGL - "Our first patent allowance could be franck92 07/22/16 11:38:45 AM
#107007   how about billions in 2015 ??? nowy257 07/22/16 11:20:57 AM
PostSubject